nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimetindene—Disopyramide—SLC22A1—hematologic cancer	0.006	0.218	CrCbGaD
Dimetindene—Chlorphenamine—SLC22A1—hematologic cancer	0.00438	0.159	CrCbGaD
Dimetindene—Clomipramine—GSTP1—hematologic cancer	0.00355	0.129	CrCbGaD
Dimetindene—Diphenhydramine—SLC22A1—hematologic cancer	0.00297	0.108	CrCbGaD
Dimetindene—Imipramine—SLC22A1—hematologic cancer	0.00224	0.0813	CrCbGaD
Dimetindene—Clomipramine—ALB—hematologic cancer	0.001	0.0363	CrCbGaD
Dimetindene—Nortriptyline—ALB—hematologic cancer	0.000979	0.0355	CrCbGaD
Dimetindene—Clomipramine—ABCB1—hematologic cancer	0.000956	0.0347	CrCbGaD
Dimetindene—Chlorprothixene—ABCB1—hematologic cancer	0.000952	0.0345	CrCbGaD
Dimetindene—Trimipramine—ABCB1—hematologic cancer	0.000879	0.0319	CrCbGaD
Dimetindene—Promethazine—ABCB1—hematologic cancer	0.000847	0.0307	CrCbGaD
Dimetindene—Doxepin—ABCB1—hematologic cancer	0.000838	0.0304	CrCbGaD
Dimetindene—Amitriptyline—ALB—hematologic cancer	0.000679	0.0246	CrCbGaD
Dimetindene—Imipramine—ABCB1—hematologic cancer	0.000652	0.0236	CrCbGaD
Dimetindene—Amitriptyline—ABCB1—hematologic cancer	0.000648	0.0235	CrCbGaD
Dimetindene—CHRM2—GPCR downstream signaling—JAK1—hematologic cancer	0.000302	0.00031	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—PRKCG—hematologic cancer	0.000302	0.00031	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—STAT5B—hematologic cancer	0.000301	0.00031	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—RAC2—hematologic cancer	0.000301	0.000309	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—DKK1—hematologic cancer	0.000299	0.000307	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—STAT5B—hematologic cancer	0.000296	0.000305	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—ADCY7—hematologic cancer	0.000292	0.000301	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CSF2—hematologic cancer	0.000288	0.000297	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—ADCY7—hematologic cancer	0.000288	0.000296	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—IL2RA—hematologic cancer	0.000286	0.000294	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—XIAP—hematologic cancer	0.000284	0.000292	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CSF2—hematologic cancer	0.000284	0.000292	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—IL2RA—hematologic cancer	0.000282	0.00029	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—XIAP—hematologic cancer	0.00028	0.000288	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PRKCG—hematologic cancer	0.000278	0.000286	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—JAK1—hematologic cancer	0.000278	0.000286	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—SMARCA4—hematologic cancer	0.000277	0.000285	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—SH2B3—hematologic cancer	0.000277	0.000285	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GZMB—hematologic cancer	0.000275	0.000283	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—JAK1—hematologic cancer	0.000274	0.000282	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PRKCG—hematologic cancer	0.000274	0.000282	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—SH2B3—hematologic cancer	0.000273	0.00028	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—SMARCA4—hematologic cancer	0.000273	0.00028	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GZMB—hematologic cancer	0.000271	0.000279	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CTNNA1—hematologic cancer	0.000269	0.000277	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—HSPB1—hematologic cancer	0.000267	0.000275	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—EIF4EBP1—hematologic cancer	0.000267	0.000275	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCL3—hematologic cancer	0.000267	0.000275	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CTNNA1—hematologic cancer	0.000265	0.000272	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PTHLH—hematologic cancer	0.000264	0.000272	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—SDC1—hematologic cancer	0.000264	0.000272	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCL3—hematologic cancer	0.000263	0.000271	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—HSPB1—hematologic cancer	0.000263	0.000271	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—EIF4EBP1—hematologic cancer	0.000263	0.000271	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—SDC1—hematologic cancer	0.00026	0.000267	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PTHLH—hematologic cancer	0.00026	0.000267	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—IL2RA—hematologic cancer	0.00026	0.000267	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PTGER4—hematologic cancer	0.000257	0.000265	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—LCK—hematologic cancer	0.000256	0.000263	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—IL2RA—hematologic cancer	0.000256	0.000263	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PTGER4—hematologic cancer	0.000253	0.00026	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—LCK—hematologic cancer	0.000252	0.000259	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—H3F3A—hematologic cancer	0.000251	0.000258	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—H3F3A—hematologic cancer	0.000247	0.000254	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PRKCZ—hematologic cancer	0.000244	0.000251	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PRKCZ—hematologic cancer	0.00024	0.000247	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—PIK3CG—hematologic cancer	0.000238	0.000245	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PARP1—hematologic cancer	0.000236	0.000242	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—PIK3CG—hematologic cancer	0.000235	0.000241	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PARP1—hematologic cancer	0.000232	0.000238	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—FBXW7—hematologic cancer	0.000232	0.000238	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—FBXW7—hematologic cancer	0.000228	0.000235	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CXCR4—hematologic cancer	0.000227	0.000234	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—HDAC2—hematologic cancer	0.000227	0.000234	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CXCR4—hematologic cancer	0.000224	0.00023	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—HDAC2—hematologic cancer	0.000224	0.00023	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CBL—hematologic cancer	0.000222	0.000228	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—IL3—hematologic cancer	0.000219	0.000225	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CBL—hematologic cancer	0.000218	0.000224	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PIK3CG—hematologic cancer	0.000217	0.000223	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—IL3—hematologic cancer	0.000216	0.000222	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PTPN1—hematologic cancer	0.000215	0.000222	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PIK3CG—hematologic cancer	0.000213	0.000219	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PTPN11—hematologic cancer	0.000213	0.000219	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PTPN1—hematologic cancer	0.000212	0.000218	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—RASGRP1—hematologic cancer	0.000212	0.000218	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—HSP90AA1—hematologic cancer	0.000211	0.000217	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—SYK—hematologic cancer	0.000211	0.000217	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—PIK3CD—hematologic cancer	0.00021	0.000216	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PTPN11—hematologic cancer	0.000209	0.000215	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—RASGRP1—hematologic cancer	0.000209	0.000215	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—HSP90AA1—hematologic cancer	0.000208	0.000214	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—SYK—hematologic cancer	0.000208	0.000214	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—PIK3CD—hematologic cancer	0.000206	0.000212	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CREB1—hematologic cancer	0.000206	0.000212	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—STAT1—hematologic cancer	0.000204	0.00021	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CREB1—hematologic cancer	0.000203	0.000209	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CCL2—hematologic cancer	0.000202	0.000207	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—IL6R—hematologic cancer	0.000201	0.000207	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—STAT1—hematologic cancer	0.000201	0.000206	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CCL2—hematologic cancer	0.000198	0.000204	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—PIK3R1—hematologic cancer	0.000198	0.000204	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—IL6R—hematologic cancer	0.000198	0.000203	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—PIK3R1—hematologic cancer	0.000195	0.0002	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—JAK2—hematologic cancer	0.000192	0.000198	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—MAP2K1—hematologic cancer	0.000192	0.000197	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GRB2—hematologic cancer	0.000191	0.000196	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PIK3CD—hematologic cancer	0.00019	0.000196	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PDGFA—hematologic cancer	0.00019	0.000196	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—JAK2—hematologic cancer	0.000189	0.000195	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—MAP2K1—hematologic cancer	0.000189	0.000194	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GRB2—hematologic cancer	0.000188	0.000193	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—KITLG—hematologic cancer	0.000187	0.000193	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PIK3CD—hematologic cancer	0.000187	0.000193	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PDGFA—hematologic cancer	0.000187	0.000192	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—KITLG—hematologic cancer	0.000184	0.00019	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—STAT5A—hematologic cancer	0.000183	0.000188	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—PIK3CB—hematologic cancer	0.000183	0.000188	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CDKN2B—hematologic cancer	0.000182	0.000187	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—STAT5A—hematologic cancer	0.00018	0.000185	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—PIK3CB—hematologic cancer	0.00018	0.000185	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PIK3R1—hematologic cancer	0.00018	0.000185	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CDKN2B—hematologic cancer	0.000179	0.000184	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PIK3R1—hematologic cancer	0.000177	0.000182	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CD86—hematologic cancer	0.000176	0.000181	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—JAK2—hematologic cancer	0.000175	0.00018	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—HES1—hematologic cancer	0.000173	0.000178	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CD86—hematologic cancer	0.000173	0.000178	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NCOR1—hematologic cancer	0.000172	0.000177	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—JAK2—hematologic cancer	0.000172	0.000177	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—HES1—hematologic cancer	0.00017	0.000175	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CSF2—hematologic cancer	0.00017	0.000175	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—FGF1—hematologic cancer	0.00017	0.000175	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NCOR1—hematologic cancer	0.00017	0.000174	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—FOXO1—hematologic cancer	0.000168	0.000173	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—IL2—hematologic cancer	0.000168	0.000173	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CSF2—hematologic cancer	0.000168	0.000172	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—FGF1—hematologic cancer	0.000168	0.000172	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PDGFRB—hematologic cancer	0.000168	0.000172	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PIK3CB—hematologic cancer	0.000166	0.000171	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—FOXO1—hematologic cancer	0.000165	0.00017	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—IL2—hematologic cancer	0.000165	0.00017	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PDGFRA—hematologic cancer	0.000165	0.00017	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PDGFRB—hematologic cancer	0.000165	0.00017	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—JAK1—hematologic cancer	0.000164	0.000169	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PRKCG—hematologic cancer	0.000164	0.000169	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PIK3CB—hematologic cancer	0.000163	0.000168	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PDGFRA—hematologic cancer	0.000162	0.000167	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—JAK1—hematologic cancer	0.000162	0.000166	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PRKCG—hematologic cancer	0.000162	0.000166	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—IL2RA—hematologic cancer	0.000154	0.000158	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—IL2—hematologic cancer	0.000152	0.000157	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—TERT—hematologic cancer	0.000152	0.000156	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—IL2RA—hematologic cancer	0.000151	0.000155	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—IL2—hematologic cancer	0.00015	0.000154	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—TERT—hematologic cancer	0.000149	0.000154	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PDGFB—hematologic cancer	0.000148	0.000152	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	0.000146	0.00015	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—TSC2—hematologic cancer	0.000145	0.000149	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—TSC2—hematologic cancer	0.000143	0.000147	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—FGFR3—hematologic cancer	0.000139	0.000143	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MAPK14—hematologic cancer	0.000138	0.000142	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	0.000137	0.000141	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	0.000136	0.00014	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—ESR1—hematologic cancer	0.000135	0.000139	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—FN1—hematologic cancer	0.000134	0.000137	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—ESR1—hematologic cancer	0.000133	0.000137	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—BAD—hematologic cancer	0.000132	0.000136	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NFKBIA—hematologic cancer	0.000132	0.000136	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—FN1—hematologic cancer	0.000132	0.000135	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NOTCH1—hematologic cancer	0.000131	0.000135	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—BAD—hematologic cancer	0.00013	0.000134	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	0.00013	0.000134	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	0.000129	0.000132	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CD80—hematologic cancer	0.000128	0.000132	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PIK3CG—hematologic cancer	0.000128	0.000132	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—KIT—hematologic cancer	0.000128	0.000132	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—NRAS—hematologic cancer	0.000128	0.000132	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CD80—hematologic cancer	0.000126	0.00013	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—KIT—hematologic cancer	0.000126	0.000129	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	0.000126	0.000129	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	0.000126	0.000129	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PTPN11—hematologic cancer	0.000126	0.000129	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	0.000124	0.000127	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—MAPK3—hematologic cancer	0.000123	0.000126	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CREB1—hematologic cancer	0.000122	0.000125	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	0.000121	0.000124	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—BRAF—hematologic cancer	0.00012	0.000124	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CREB1—hematologic cancer	0.00012	0.000123	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCL2—hematologic cancer	0.000119	0.000123	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—IL6R—hematologic cancer	0.000119	0.000122	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CREBBP—hematologic cancer	0.000119	0.000122	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—BRAF—hematologic cancer	0.000118	0.000122	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCL2—hematologic cancer	0.000117	0.000121	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—IL6R—hematologic cancer	0.000117	0.00012	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	0.000117	0.00012	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MAP2K1—hematologic cancer	0.000113	0.000116	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PIK3CD—hematologic cancer	0.000112	0.000116	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000111	0.000115	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	0.000111	0.000115	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	0.000111	0.000114	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—KRAS—hematologic cancer	0.00011	0.000113	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	0.00011	0.000113	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	0.000108	0.000111	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—FGF2—hematologic cancer	0.000108	0.000111	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PIK3R1—hematologic cancer	0.000106	0.000109	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—FGF2—hematologic cancer	0.000106	0.000109	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	0.000104	0.000107	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—JAK2—hematologic cancer	0.000103	0.000106	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—JAK2—hematologic cancer	0.000102	0.000104	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PIK3CA—hematologic cancer	0.000101	0.000104	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MDM2—hematologic cancer	0.000101	0.000104	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	9.95e-05	0.000102	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MDM2—hematologic cancer	9.91e-05	0.000102	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MTOR—hematologic cancer	9.8e-05	0.000101	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PIK3CB—hematologic cancer	9.8e-05	0.000101	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MTOR—hematologic cancer	9.64e-05	9.92e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	9.64e-05	9.92e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—HRAS—hematologic cancer	9.36e-05	9.62e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	9.21e-05	9.47e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CDKN1B—hematologic cancer	9.2e-05	9.46e-05	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—AKT1—hematologic cancer	9.1e-05	9.36e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	9.05e-05	9.31e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CASP3—hematologic cancer	9.02e-05	9.27e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—IL2—hematologic cancer	9e-05	9.26e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—IL6—hematologic cancer	8.96e-05	9.21e-05	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	8.95e-05	9.21e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CASP3—hematologic cancer	8.87e-05	9.12e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—IL2—hematologic cancer	8.86e-05	9.11e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—IL6—hematologic cancer	8.81e-05	9.06e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCND1—hematologic cancer	8.78e-05	9.02e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—JUN—hematologic cancer	8.76e-05	9.01e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCND1—hematologic cancer	8.63e-05	8.88e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—JUN—hematologic cancer	8.62e-05	8.86e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	8.49e-05	8.73e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PTEN—hematologic cancer	8.47e-05	8.71e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	8.35e-05	8.59e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PTEN—hematologic cancer	8.33e-05	8.57e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MAPK8—hematologic cancer	8.29e-05	8.52e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—AKT1—hematologic cancer	8.26e-05	8.5e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	8.15e-05	8.38e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	8.13e-05	8.36e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—EP300—hematologic cancer	8.08e-05	8.31e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—EP300—hematologic cancer	7.95e-05	8.17e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—SRC—hematologic cancer	7.85e-05	8.08e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—SRC—hematologic cancer	7.73e-05	7.95e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—VEGFA—hematologic cancer	7.65e-05	7.87e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—STAT3—hematologic cancer	7.58e-05	7.79e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NRAS—hematologic cancer	7.56e-05	7.77e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	7.53e-05	7.74e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—STAT3—hematologic cancer	7.45e-05	7.67e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NRAS—hematologic cancer	7.44e-05	7.65e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MAPK3—hematologic cancer	7.24e-05	7.44e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	7.12e-05	7.32e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MYC—hematologic cancer	7.04e-05	7.24e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—TGFB1—hematologic cancer	7.02e-05	7.22e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MYC—hematologic cancer	6.93e-05	7.12e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	6.91e-05	7.11e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—KRAS—hematologic cancer	6.5e-05	6.69e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—KRAS—hematologic cancer	6.4e-05	6.58e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	5.98e-05	6.14e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	5.88e-05	6.05e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—TP53—hematologic cancer	5.78e-05	5.94e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—TP53—hematologic cancer	5.69e-05	5.85e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—HRAS—hematologic cancer	5.53e-05	5.69e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—HRAS—hematologic cancer	5.44e-05	5.59e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—IL6—hematologic cancer	5.29e-05	5.44e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—IL6—hematologic cancer	5.21e-05	5.35e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—AKT1—hematologic cancer	4.88e-05	5.02e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—AKT1—hematologic cancer	4.8e-05	4.94e-05	CbGpPWpGaD
